Devereux, Christopher – Trademark Portfolio
Entity Type: 01
Devereux, Christopher has 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO). Notable registered marks include TAIL BLAZERS. The portfolio includes 1 registered trademark. Filings span 5 Nice Classification classes, led by Class 5 (Pharmaceuticals) and Class 24 (Fabrics). This trademark owner is based in Bath.
Flat 4, 7 Mount Beacon
Bath BA15QP , GB
Showing of trademarks Trademarks
Trademark Classifications
Devereux, Christopher's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Leather and imitations of leather; animal skins, hides; trunks and travelling bags
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Games and playthings; gymnastic and sporting articles; decorations for Christmas trees
Frequently Asked Questions
How many trademarks does Devereux, Christopher have?
Devereux, Christopher has 6 U.S. trademarks filed with the USPTO. Of these, 1 registered, 5 abandoned.
What trademark classes does Devereux, Christopher file in?
Devereux, Christopher files trademarks across 5 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 24 (Fabrics), Class 18 (Leather Goods), Class 16 (Paper Goods), Class 28 (Toys & Sporting Goods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Devereux, Christopher's most well-known trademarks?
Devereux, Christopher's registered trademark portfolio includes well-known marks such as TAIL BLAZERS. These are among 1 currently registered trademark in the portfolio.
What is Devereux, Christopher's trademark registration success rate?
Devereux, Christopher has a 17% trademark registration rate, with 1 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.